Literature DB >> 23983977

Case reports of patients with treatment-resistant schizophrenia and related psychotic disorders intolerant to clozapine responding to high doses of quetiapine.

Poornima Chandrappa1, Luk Ho.   

Abstract

Entities:  

Year:  2012        PMID： 23983977      PMCID： PMC3736949          DOI： 10.1177/2045125312451265

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  5 in total

Review 1.  Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Authors:  S Kapur; P Seeman
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

2.  High-dose quetiapine in treatment refractory schizophrenia.

Authors:  Joseph M Pierre; Donna A Wirshing; William C Wirshing; J Michael Rivard; Russell Marks; John Mendenhall; Karen Sheppard; David G Saunders
Journal:  Schizophr Res       Date:  2005-03-01       Impact factor: 4.939

3.  Quetiapine at high doses for the treatment of refractory schizophrenia.

Authors:  Douglas L Boggs; Deanna L Kelly; Stephanie Feldman; Robert P McMahon; Matthew W Nelson; Yang Yu; Robert R Conley
Journal:  Schizophr Res       Date:  2008-02-20       Impact factor: 4.939

4.  A randomized, double-blind, placebo-controlled study of the safety and tolerability of high-dose quetiapine in patients with persistent symptoms of schizophrenia or schizoaffective disorder.

Authors:  William G Honer; G William MacEwan; Alain Gendron; Emmanuel Stip; Alain Labelle; Richard Williams; Hans Eriksson
Journal:  J Clin Psychiatry       Date:  2011-06-14       Impact factor: 4.384

5.  Efficacy, safety and tolerability of quetiapine: short-term high doses with long-term follow-up.

Authors:  Judit Nagy
Journal:  Int J Psychiatry Clin Pract       Date:  2005       Impact factor: 1.812
  5 in total
  1 in total

Review 1.  Observational studies and their utility for practice.

Authors:  Julia Fm Gilmartin-Thomas; Danny Liew; Ingrid Hopper
Journal:  Aust Prescr       Date:  2018-06-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.